More Information on 'BIOTON S.A.'

Bioton is a pharmaceutical company that specializes in providing comprehensive solutions for diabetes treatment. The company's core business involves the manufacture and supply of insulin, insulin pens, and other medical devices for diabetes patients. Bioton operates a state-of-the-art manufacturing facility in Poland, where it produces high-quality pharmaceuticals, including insulin, while adhering to international standards and regulations. In addition to its products, the company also provides patient education and support services, including educational materials, a hotline, and online resources to help patients manage their condition. Furthermore, Bioton invests in research and development to create innovative solutions for diabetes treatment, collaborating with experts in the field to develop new products and therapies.

About BIOTON S.A.
BIOTON aims to reinforce its position of a biotechnological company with a global reach. The Company is able to pursue its strategic objectives of protecting Patients’ health and improving the quality of their lives by participating in research and development projects, promoting the expansion of its product portfolio and making well-informed business decisions. BIOTON fulfils its stated mission by implementing strategies and development plans aimed at: reinforcing BIOTON's status on the Polish insulin market promoting BIOTON's insulin world-wide by maximising its share of the existing markets and entering new ones developing innovative, clinically important medicinal products, including biotechnological drugs developed by members of the BIOTON Group expanding BIOTON’s generic drug portfolio.